Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
BPH Impact IndexBosniak ClassificationCAPRA ScoreD'Amico Risk ClassificationEAU NMIBC Risk Groups (2021)EORTC Risk Tables for NMIBCFournier's Gangrene Severity IndexGUPI (Genitourinary Pain Index)Guy's Stone ScoreICIQ-UI SFIGCCCG ClassificationIIEF-5 / SHIMIIQ-7IMDC (Heng) Risk CriteriaIPSS ScoreNIH-CPSIOAB-V8PADUA Prediction ScorePI-RADS v2.1PSA DensityR.E.N.A.L. Nephrometry ScoreResidual Volume (PVR)S.T.O.N.E. NephrolithometrySFU Hydronephrosis GradingUDI-6VUR Grading
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Recent Journal Updates

British J Clinical PharmacologyJun 18, 2026
Applying machine learning to pharmacovigilance data: A proof‐of‐concept study

Clinical Context

We think this has broad domain relevance to ICIQUISF.

ICIQ-UI SF

Urinary Incontinence Assessment

ICIQ-UI Short Form

0 = Not at all10 = A great deal

Awaiting Responses

Answer the 3 scored questions to calculate incontinence severity.

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

When to Use the ICIQ-UI SF

Initial screening and assessment of urinary incontinence (stress, urgency, mixed, overflow, or continuous) in women and men
Baseline evaluation before any incontinence treatment (pelvic floor therapy, medications, pessary, or surgery)
Monitoring treatment response at 6–12 weeks and 3–12 months post-intervention
Clinical trials as a primary or secondary outcome measure (highly responsive to change)
Screening in high-risk populations: postpartum women, postmenopausal women, elderly, post-prostatectomy men, neurogenic bladder (MS, Parkinson’s, stroke), obesity, diabetes
Differentiating incontinence types using the diagnostic question (Q4)
Quality improvement programs and benchmarking incontinence severity in clinical practice

Clinical Utility

The ICIQ-UI SF is a brief, robust, and internationally validated tool that evaluates the frequency and amount of urine leakage as well as its impact on quality of life. It is recommended by the International Continence Society (ICS) and is widely used due to its simplicity, excellent psychometric properties, and availability in over 50 languages. It correlates well with objective measures such as the pad test and is sensitive to clinically meaningful change.

Last Comprehensive Review: 2026